RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.

Journal: 
Nat Genet
Publication Year: 
2014
Authors: 
Elli Papaemmanuil
Inmaculada Rapado
Yilong Li
Nicola E Potter
David C Wedge
Jose Tubio
Ludmil B Alexandrov
Peter Van Loo
Susanna L Cooke
John Marshall
Inigo Martincorena
Jonathan Hinton
Gunes Gundem
Frederik W van Delft
Serena Nik-Zainal
David R Jones
Manasa Ramakrishna
Ian Titley
Lucy Stebbings
Catherine Leroy
Andrew Menzies
John Gamble
Ben Robinson
Laura Mudie
Keiran Raine
Sarah O'Meara
Jon W Teague
Adam P Butler
Giovanni Cazzaniga
Andrea Biondi
Jan Zuna
Helena Kempski
Markus Muschen
Anthony M Ford
Michael R Stratton
Mel Greaves
Peter J Campbell
PubMed link: 
24413735
Public Summary: 
The ETV6-RUNX1 fusion gene, found in 25% of childhood acute lymphoblastic leukemia (ALL) cases, is acquired in utero but requires additional somatic mutations for overt leukemia. We used exome and low-coverage whole-genome sequencing to characterize secondary events associated with leukemic transformation. RAG-mediated deletions emerge as the dominant mutational process, characterized by recombination signal sequence motifs near breakpoints, incorporation of non-templated sequence at junctions, approximately 30-fold enrichment at promoters and enhancers of genes actively transcribed in B cell development and an unexpectedly high ratio of recurrent to non-recurrent structural variants. Single-cell tracking shows that this mechanism is active throughout leukemic evolution, with evidence of localized clustering and reiterated deletions. Integration of data on point mutations and rearrangements identifies ATF7IP and MGA as two new tumor-suppressor genes in ALL. Thus, a remarkably parsimonious mutational process transforms ETV6-RUNX1-positive lymphoblasts, targeting the promoters, enhancers and first exons of genes that normally regulate B cell differentiation.
Scientific Abstract: 
The ETV6-RUNX1 fusion gene, found in 25% of childhood acute lymphoblastic leukemia (ALL) cases, is acquired in utero but requires additional somatic mutations for overt leukemia. We used exome and low-coverage whole-genome sequencing to characterize secondary events associated with leukemic transformation. RAG-mediated deletions emerge as the dominant mutational process, characterized by recombination signal sequence motifs near breakpoints, incorporation of non-templated sequence at junctions, approximately 30-fold enrichment at promoters and enhancers of genes actively transcribed in B cell development and an unexpectedly high ratio of recurrent to non-recurrent structural variants. Single-cell tracking shows that this mechanism is active throughout leukemic evolution, with evidence of localized clustering and reiterated deletions. Integration of data on point mutations and rearrangements identifies ATF7IP and MGA as two new tumor-suppressor genes in ALL. Thus, a remarkably parsimonious mutational process transforms ETV6-RUNX1-positive lymphoblasts, targeting the promoters, enhancers and first exons of genes that normally regulate B cell differentiation.